Interleukin-6 and acute coronary syndrome

Clinical Cardiology

Volumn 24, Issue 11, 2001, Pages 701-704

  Ikeda, U ^a   Ito, T ^a   Shimada, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angina pectoris; Cytokine; Inflammation; Myocardial infarction; Restenosis

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY SINUS; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; UNSTABLE ANGINA PECTORIS;

EID: 0034759210     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960241103     Document Type: Review

References (33)

1. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity
2. Induction of low-density lipoprotein receptor and transcription factor SP-1 by tumor necrosis factor in human vascular endothelial cells
3. Cytokine-stimulated smooth muscle cells stimulate a complement of enzymes required for extracellular matrix digestion
4. Interleukin 6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line
5. Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by pro-inflammatory cytokines
6. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
7. The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment
8. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina
9. Production of C-reactive protein and risk of coronary events in stable and unstable angina
10. Serum interleukin 6 levels become elevated in acute myocardial infarction
11. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: A pilot study
12. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions
13. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
14. Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction
15. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
16. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of repeffused infarctions
17. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease
18. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina
19. Procoagulant and proinflammatory activity in acute coronary syndromes
20. Increasing levels of interleukin (IL)- 1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
21. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions
22. Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis
23. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis
24. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
25. Elevated levels of interleukin-6 in unstable angina
26. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
27. Production of C-reactive protein and the risk of cardiovascular disease in apparently healthy men
28. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol level
29. Statins do more than just lower cholesterol
30. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
31. Statins and C-reactive protein
32. Lipophilic HHMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of mRNA levels for interleukin-1β, interleukin 6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
33. Non-lipid lowering effects of statin medication in patients with coronary heart disease